Overview
You are a business development manager for a life sciences organization in the Midwest that has recently found great success through their new cancer treatment drugs. You are part of the team that is planning your organization’s exit strategy, as the owners want to sell the business. As you continue to gather and analyze data to include in your strategic recommendations, you hear about a possible roadblock that can affect your plans.
There is currently one prospective buyer interested in acquiring your organization. Your team has started planning for the acquisition process based on this interest. However, you receive word that due to recent economic and market instability, the buyer is now reconsidering its acquisition proposal. If this buyer backs out, your organization will have to re-evaluate its strategy.
To ensure the organization’s readiness in case of a setback, the VP of business development wants you and your team to identify alternative scenarios and draft a contingency plan. Your team agrees with this approach and decides to perform some preliminary research that will not only help in your acquisition analysis but will also help identify alternative buyers in the event the current buyer backs out.
In this report, you will identify and research the top three organizations in your industry and market. You will then summarize this information in a report to your VP as the list of companies to consider if they decide to look for an alternative buyer.
Prompt
Create a report summarizing the competitor analysis for three of the best performing organizations in the life sciences industry, focusing on pharmaceuticals and medicines.
Specifically, you must address the following criteria:
- North American Industry Classification System (NAICS) code: Identify the NAICS Code from the NAICS website for the organization (a life sciences firm producing cancer treatment drugs) in the course scenario. Make sure the NAICS code relates to either the oncology, pharmaceutical, or medicines sectors.
- How will you use the code to find potential buyers in your segment?
- Top competitors: Identify the top three organizations in the same industry with the same NAICS code as the organization in the course scenario and explain three criteria you used for shortlisting these companies. Use resources such as IBISWorld, Mergent Market Atlas, and GlobalData to help you in your research. Consider the following in your response:
- Why did you select these three criteria?
- How do these three criteria impact the organization?
- What other criteria did you consider but not use? Why did you not use those criteria?
- Company information: Summarize the following information for the three competitors and potential alternative buyers. Use resources like investor relations pages on the organizations’ websites and GlobalData to help you in your research. (Consider using a table to capture this information.)
- Strategic vision (if available)
- Primary product(s) or service(s)
- Overall market share
- Compound annual growth rate (CAGR)
How to Write a Competitor Analysis Report for a Life Sciences Organization
Introduction
Begin by introducing the importance of competitor analysis in supporting mergers and acquisitions (M&A), strategic planning, and business development within the life sciences industry. Explain that organizations preparing for acquisition must evaluate potential buyers, industry trends, competitive positioning, and market performance to minimize uncertainty and maximize organizational value. Discuss how the current economic environment and market volatility can influence acquisition decisions, making contingency planning an essential component of business strategy. Conclude the introduction by stating that the report will identify the appropriate NAICS code for the organization, evaluate leading pharmaceutical competitors as potential alternative buyers, and summarize strategic information that will support acquisition planning and contingency decision-making.
Section 1: North American Industry Classification System (NAICS) Code
Identify the most appropriate NAICS code for the organization described in the case scenario.
Include:
Official NAICS code.
Industry title.
Industry description.
Relationship to oncology, pharmaceuticals, or medicines.
Explain why the selected NAICS classification accurately represents a life sciences company that develops and manufactures cancer treatment drugs.
Discuss how the NAICS code can be used to:
Identify organizations within the same industry.
Locate potential acquisition partners.
Analyze market competition.
Conduct industry benchmarking.
Support strategic market research.
Evaluate potential buyers operating within the oncology and pharmaceutical sectors.
Section 2: Identifying the Top Three Competitors
Identify three leading pharmaceutical or life sciences organizations operating within the same NAICS classification that could serve as potential alternative buyers.
Examples may include organizations such as:
Pfizer.
Merck & Co.
Bristol Myers Squibb.
Roche.
AstraZeneca.
Johnson & Johnson Innovative Medicine.
Novartis.
Amgen.
Eli Lilly.
AbbVie.
Select the three organizations that best align with the organization’s oncology focus and acquisition strategy.
Explain why each company is a viable potential buyer.
Section 3: Criteria Used to Shortlist the Competitors
Explain the three criteria used to select the competitors.
Possible evaluation criteria include:
Market capitalization.
Oncology product portfolio.
Financial performance.
Revenue growth.
Research and development investment.
Market share.
Global presence.
Acquisition history.
Strategic alignment.
Innovation capability.
Pipeline strength.
Operational scale.
Explain:
Why each criterion was selected.
How each criterion affects acquisition suitability.
Why these criteria are particularly important when evaluating strategic buyers in the pharmaceutical industry.
Also discuss other criteria that were considered but ultimately not selected, such as:
Geographic proximity.
Number of employees.
Brand recognition.
Patent portfolio size.
Corporate culture.
Manufacturing capacity.
Explain why these factors were less influential for this analysis.
Section 4: Competitor Company Information
Create one original comparison table summarizing each competitor.
The table should include:
Company name.
Strategic vision or mission.
Primary oncology products or pharmaceutical services.
Major therapeutic areas.
Overall market share.
Compound Annual Growth Rate (CAGR).
Financial performance.
Research and development focus.
Global presence.
Potential strategic fit as an acquirer.
Use information obtained from:
Investor Relations reports.
Annual reports.
GlobalData.
IBISWorld.
Mergent Market Atlas.
Other reputable industry databases.
Explain how the comparison supports executive decision-making.
Section 5: Strategic Analysis of the Competitors
Evaluate each organization’s competitive position.
Discuss:
Business strategy.
Competitive advantages.
Innovation.
Research capabilities.
Product diversification.
Financial stability.
Acquisition strategy.
Global expansion.
Risk profile.
Long-term growth potential.
Explain which competitor appears to represent the strongest strategic acquisition partner and why.
Section 6: Contingency Planning for Alternative Buyers
Develop recommendations for contingency planning should the original prospective buyer withdraw.
Discuss:
Diversification of potential buyers.
Market intelligence.
Strategic partnerships.
Confidential outreach.
Due diligence.
Valuation updates.
Negotiation strategies.
Risk mitigation.
Competitive positioning.
Communication planning.
Explain how maintaining a qualified list of alternative buyers reduces acquisition risk and strengthens the organization’s negotiating position.
Section 7: Executive Recommendations
Provide evidence-based recommendations for senior leadership.
Discuss recommendations regarding:
Buyer prioritization.
Market positioning.
Strategic communications.
Due diligence preparation.
Financial readiness.
Competitive intelligence.
Industry monitoring.
Long-term acquisition strategy.
Explain how these recommendations improve organizational preparedness and increase the likelihood of a successful acquisition.
Conclusion
Summarize the importance of competitor analysis in supporting acquisition planning and contingency strategy within the life sciences industry. Reinforce that identifying organizations operating under the same NAICS classification provides a structured approach for evaluating potential buyers and benchmarking competitive performance. Conclude by emphasizing that careful analysis of strategic vision, oncology product portfolios, market share, financial growth, and organizational capabilities enables leadership to make informed acquisition decisions while reducing uncertainty in a changing economic environment.
References
Prepare a References page using APA 7th edition formatting unless your instructor specifies another citation style. Arrange all references in alphabetical order without numbering. Include authoritative sources such as the NAICS website, IBISWorld, GlobalData, Mergent Market Atlas, company Investor Relations and Annual Reports, U.S. Census Bureau, SEC filings, and any required course materials. Ensure that all in-text citations correspond accurately to the reference list.
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|